Literature DB >> 31326254

Cholera surveillance and estimation of burden of cholera.

Divya Ganesan1, Sanjukta Sen Gupta2, Dominique Legros3.   

Abstract

Cholera continues to be poorly controlled in multiple epidemic and endemic areas across the globe, with estimated annual incidence of 1.3-4.0 million cases, resulting in 21,000 to 143,000 deaths worldwide in 2015. The usual approach for patient diagnosis and cholera surveillance is clinical examination of cases of acute watery diarrhea (AWD), confirmed by positive culture or polymerase chain reaction tests. Rapid diagnostic tests (RDTs) are used in regions with limited laboratory capacities but have been found to demonstrate large variations in performance, ranging in sensitivity from 58% to 100% and in specificity from 60% to 100%. Most countries rely on hospital-based surveillance of diarrheal disease to compute the cholera burden. The World Health Organization (WHO) recommends that countries assess public health events involving cholera against the International Health Regulations 2005 criteria and determine need for official notification using the standard case definition. Cholera is an often under-recognized and under reported problem because of differences in case definitions, reluctance by authorities to acknowledge and report cholera, inadequacies in hospital surveillance systems, lack of effective diagnostic tests and commonalities in clinical presentation of cholera with other AWD etiologies. The resulting gap in burden data impairs economic analysis of disease impact and identification of areas for targeted control interventions. There is an urgent need to strengthen surveillance data by supplementing reported numbers with estimates from literature reviews and data from modelling studies, developing better-performing RDTs, enhancing monitoring and evaluation processes of in-country surveillance systems, and encouraging countries to report cholera cases by "rewarding" better reporting with technical support and improved access to vaccines. It is imperative that immediate steps are taken towards strengthening surveillance and reporting systems globally, especially in cholera-prone and resource-limited areas, where it will enable countries to articulate their demand for resources more accurately.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Barriers; Cholera; Disease burden; Reporting; Surveillance; WHO

Mesh:

Year:  2019        PMID: 31326254     DOI: 10.1016/j.vaccine.2019.07.036

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

Review 1.  Diagnosis, Management, and Future Control of Cholera.

Authors:  Fahima Chowdhury; Allen G Ross; Md Taufiqul Islam; Nigel A J McMillan; Firdausi Qadri
Journal:  Clin Microbiol Rev       Date:  2022-06-21       Impact factor: 50.129

2.  Vibrio cholerae O139 genomes provide a clue to why it may have failed to usher in the eighth cholera pandemic.

Authors:  Thandavarayan Ramamurthy; Agila Kumari Pragasam; Alyce Taylor-Brown; Robert C Will; Karthick Vasudevan; Bhabatosh Das; Sunil Kumar Srivastava; Goutam Chowdhury; Asish K Mukhopadhyay; Shanta Dutta; Balaji Veeraraghavan; Nicholas R Thomson; Naresh C Sharma; Gopinath Balakrish Nair; Yoshifumi Takeda; Amit Ghosh; Gordon Dougan; Ankur Mutreja
Journal:  Nat Commun       Date:  2022-07-05       Impact factor: 17.694

Review 3.  Vaccines and Senior Travellers.

Authors:  Fiona Ecarnot; Stefania Maggi; Jean-Pierre Michel; Nicola Veronese; Andrea Rossanese
Journal:  Front Aging       Date:  2021-07-09

4.  Infectious Disease Control and Management in Ethiopia: A Case Study of Cholera.

Authors:  Se Eun Park; Yeonji Jeon; Sunjoo Kang; Abel Gedefaw; Dejene Hailu; Biruk Yeshitela; Moti Edosa; Mesfin Wossen Getaneh; Mekonnen Teferi
Journal:  Front Public Health       Date:  2022-05-30

5.  Cholera diagnosis in human stool and detection in water: A systematic review and meta-analysis.

Authors:  Jennifer Falconer; Karin Diaconu; Fiona O'May; Advaith Gummaraju; Ifeyinwa Victor-Uadiale; Joseph Matragrano; Berthe-Marie Njanpop-Lafourcade; Alastair Ager
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

6.  H-NS and ToxT Inversely Control Cholera Toxin Production by Binding to Overlapping DNA Sequences.

Authors:  Jennifer B Stone; Jeffrey H Withey
Journal:  J Bacteriol       Date:  2021-08-20       Impact factor: 3.490

Review 7.  Prevention and control of cholera with household and community water, sanitation and hygiene (WASH) interventions: A scoping review of current international guidelines.

Authors:  Lauren D'Mello-Guyett; Karin Gallandat; Rafael Van den Bergh; Dawn Taylor; Gregory Bulit; Dominique Legros; Peter Maes; Francesco Checchi; Oliver Cumming
Journal:  PLoS One       Date:  2020-01-08       Impact factor: 3.240

8.  Laboratory evaluation of the rapid diagnostic tests for the detection of Vibrio cholerae O1 using diarrheal samples.

Authors:  Goutam Chowdhury; Tarosi Senapati; Bhabatosh Das; Asha Kamath; Debottam Pal; Puja Bose; Arundhati Deb; Sangita Paul; Asish K Mukhopadhyay; Shanta Dutta; Thandavarayan Ramamurthy
Journal:  PLoS Negl Trop Dis       Date:  2021-06-15

9.  The impact of improved water supply on cholera and diarrhoeal diseases in Uvira, Democratic Republic of the Congo: a protocol for a pragmatic stepped-wedge cluster randomised trial and economic evaluation.

Authors:  Karin Gallandat; Aurélie Jeandron; Ian Ross; Jaime Mufitini Saidi; Baron Bashige Rumedeka; Vercus Lumami Kapepula; Simon Cousens; Elizabeth Allen; Amy MacDougall; Oliver Cumming
Journal:  Trials       Date:  2021-06-21       Impact factor: 2.728

10.  Sachet water consumption as a risk factor for cholera in urban settings: Findings from a case control study in Kinshasa, Democratic Republic of the Congo during the 2017-2018 outbreak.

Authors:  Placide Mbala-Kingebeni; Florian Vogt; Berthe Miwanda; Tresor Sundika; Nancy Mbula; Isaac Pankwa; Leopold Lubula; Veerle Vanlerberghe; Alain Magazani; Mildred Tita Afoumbom; Jean-Jacques Muyembe-Tamfum
Journal:  PLoS Negl Trop Dis       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.